ArticleNPJ Parkinson's disease2026
A stacked multi-classifier for multi-modal data fusion in transcranial sonography-based Parkinson's disease assessment.
Article in NPJ Parkinson's disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Parkinson's disease (PD) is a catastrophic neurodegenerative disorder and a major culprit of neurological disability worldwide. Accurate diagnosis of PD, especially in its early stages, is paramount for timely intervention and effective therapeutic management. However, contemporary clinical diagnostic methods are hindered by the complexities of procedures, inter-evaluator subjectivity, and challenges related to the accuracy and reproducibility of diagnoses. This study employs transcranial sonography (TCS)-a non-invasive, widely accessible, and highly affordable neuroimaging-and integrates radiomic analysis with deep learning via a stacked multimodal ensemble model for PD assessment. A retrospective cohort of 324 participants (103 with PD and 221 Non-PD controls) was recruited from Beijing Tiantan Hospital. The development of the proposed model involved systematically evaluating its performance across different combinations of clinical, radiomic, and deep learning features. The results demonstrated that: The integration of multimodal features-clinical, radiomic, and deep learning-consistently improved predictive performance across all ensemble methods (Bagging, Boosting, and Stacking classifiers). The Stacking ensemble (RF, XGB and HGBDT) model achieved the best performance using the combined feature set, with an AUC of 0.915 (0.002), PR-AUC of 0.868 (0.005), accuracy of 0.810 (0.019), and precision of 0.968 (0.040), with values reported as mean (standard deviation). Diagnostic efficacy including TCS grading significantly exceeded that without TCS, underscoring its clinical value in PD assessment. Furthermore, decision curve analyses showcased that the stacked multi-classifier (RF, XGB, and HGBDT) yielded the greatest net benefit across a wide range of threshold probabilities compared with other comparing methods. These findings suggest that the proposed Stacking model may serve as a promising TCS-based multimodal tool for PD assessment.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.